Isothiazole Derivatives Useful as Anticancer Agents

Details for Australian Patent Application No. 2004202433 (hide)

Owner Pfizer Products Inc.

Inventors Noe, Mark Carl; Gant, Thomas George; Larson, Eric Robert

Agent Spruson & Ferguson

Pub. Number AU-B-2004202433

Parent 33421

Filing date 2 June 2004

Wipo publication date 1 July 2004

Acceptance publication date 19 April 2007

International Classifications

C07D 275/03 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

A61K 31/425 (2006.01) - Thiazoles

C07C 33/46 (2006.01) Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms

C07C 327/58 (2006.01) Thiocarboxylic acids

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

17 June 2004 Complete Application Filed

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2004202433

19 April 2007 Application Accepted

  Published as AU-B-2004202433

16 August 2007 Standard Patent Sealed

11 June 2009 Assignment Registered

  Pfizer Products Inc. The patent has been assigned to Pfizer Inc.; OSI Pharmaceuticals, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004202434-Cyclone Dust-collector

2004202432-Grid for use in CT-guided biopsy